Bv-AVEPC Regimen

Preferred Label : Bv-AVEPC Regimen;

NCIt synonyms : Brentuximab Vedotin with AVE-PC; Brentuximab Vedotin/Cyclophosphamide/Doxorubicin//Etoposide/Prednisone/Vincristine; Brentuximab Vedotin/Doxorubicin/Vincristine/Etoposide/Prednisone/Cyclophosphamide; Cyclophosphamide-Hydroxydaunorubicin-Oncovin-Prednisone-Etoposide/Brentuximab Vedotin Regimen; Cyclophosphamide/Doxorubicin/Etoposide/Prednisone/Vincristine/Brentuximab Vedotin; Brentuximab Vedotin/Cyclophosphamide/Doxorubicin/Etoposide/Prednisone/Vincristine Regimen; AVEPC-Adcetris; AVEPC-Adcetris Regimen; AVEPC-Brentuximab Vedotin; Adcetris-Cyclophosphamide/Doxorubicin//Etoposide/Prednisone/Vincristine; Brentuximab Vedotin/Adriamycin/Vincristine/Etoposide/Prednisone/Cyclophosphamide; AVE-PC-Brentuximab Vedotin Regimen; Brentuximab Vedotin with AVEPC Regimen; BV-AVE-PC Regimen; BV-AVEPC;

NCIt definition : A regimen consisting of cyclophosphamide, doxorubicin, etoposide, prednisone, vincristine and brentuximab vedotin used to treat pediatric Hodgkin lymphoma (HL).;

NCI Metathesaurus CUI : CL1904906;

Codes from synonyms : 13998;

Détails

Origin ID

C191204;

UMLS CUI

C5784296;

Semantic type(s)
- Therapeutic or Preventive Procedure [UMLS semantic type]
chemotherapy_regimen_has_component
- Brentuximab Vedotin [NCIt concept]
- Cyclophosphamide [NCIt concept]
- Doxorubicin [NCIt concept]
- Etoposide [NCIt concept]
- Prednisone [NCIt concept]
- Vincristine [NCIt concept]
concept_is_in_subset
- HemOnc Regimen Terminology [NCIt concept]
- Multi-agent Therapeutic Regimens [NCIt concept]
- Pharmacotherapy Regimens [NCIt concept]
regimen_has_accepted_use_for_disease
- Childhood Hodgkin Lymphoma [NCIt concept]

Position du mot-clé dans l'(les) arborescence(s) :

Vous pouvez consulter :

recommendations
documents concerning education
documents for patients